ArticleFrontiers in veterinary science2026
Owner reported prevalence of autonomic signs in epileptic dogs.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Epilepsy is a common neurological disorder in dogs. Autonomic manifestations are commonly recognised but poorly reported in veterinary literature. This study aimed to determine owner reported prevalence and course of autonomic signs in epileptic dogs. Methods: A survey for owners of dogs with epilepsy created with Qualtrics was circulated on Facebook between March 2025 and August 2025. Results: There were 1,154 responses, with 704 included in statistical analysis. The overall frequency of autonomic signs was 697/704 dogs (99.0%). When analysed by body system, gastrointestinal signs [96.9% (682/704)], and urogenital signs [91.1% (641/704)] were most common. Individually, commonly reported signs included ptyalism [87.6% (617/704)], urination [79.1% (556/703)], polydipsia [78.4% (551/703)], mydriasis [71.8% (505/703)], and owner-reported appetite changes [73.9% (520/704)]; the latter could not be confidently attributed to seizure-associated autonomic dysfunction. The least prevalent were priapism [14.6% (66/452)], apnoea [16.7% (117/701)], anisocoria [18.8% (132/702)], cyanosis [20.5% (144/702)], and abdominal pain [21.3% (150/703)]. Antiseizure drugs, defined as any medications used for epileptic seizure control for both acute and maintenance management, were significantly associated with increased prevalence of several autonomic signs. Additionally, mean course of progression (deterioration) rate (3.6%) was significantly higher than mean course of regression (improvement) rate (2.9%; Conclusion: This study demonstrated that autonomic signs are ubiquitous in epileptic dogs, progression of autonomic signs is uncommon, and progression occurs more often than regression. The prevalence of autonomic signs in epileptic dogs appears to be significantly higher than previously reported. Additionally, changes in the course of autonomic signs indicate the need to monitor autonomic activity in individuals managed for epilepsy, due to the potential impact on quality of life (QoL).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.